158 related articles for article (PubMed ID: 37196887)
1. Health Characteristics and Aspirin Use in Participants at the Baseline of the ASPirin in Reducing Events in the Elderly - eXTension (ASPREE-XT) Observational Study.
Ernst ME; Broder JC; Wolfe R; Woods RL; Nelson MR; Ryan J; Shah RC; Orchard SG; Chan AT; Espinoza SE; Wilson M; Kirpach B; Reid CM; McNeil JJ; Williamson JD; Murray AM;
Contemp Clin Trials; 2023 Jul; 130():107231. PubMed ID: 37196887
[TBL] [Abstract][Full Text] [Related]
2. Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study.
McNeil JJ; Woods RL; Nelson MR; Murray AM; Reid CM; Kirpach B; Storey E; Shah RC; Wolfe RS; Tonkin AM; Newman AB; Williamson JD; Lockery JE; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Trevaks RE; Orchard SG; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Grimm RH;
J Gerontol A Biol Sci Med Sci; 2017 Oct; 72(11):1586-1593. PubMed ID: 28329340
[TBL] [Abstract][Full Text] [Related]
3. Expanded statistical analysis plan for legacy and long-term effects of aspirin in the ASPREE-XT observational follow-up study of participants in the ASPREE randomized trial.
Wolfe R; Broder J; Chan A; Murray A; Orchard S; Polekhina G; Ryan J; Tonkin A; Webb K; Woods R
medRxiv; 2023 Sep; ():. PubMed ID: 37745426
[TBL] [Abstract][Full Text] [Related]
4. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial.
ASPREE Investigator Group
Contemp Clin Trials; 2013 Nov; 36(2):555-64. PubMed ID: 24113028
[TBL] [Abstract][Full Text] [Related]
5. ASPREE-NEURO study protocol: A randomized controlled trial to determine the effect of low-dose aspirin on cerebral microbleeds, white matter hyperintensities, cognition, and stroke in the healthy elderly.
Ward SA; Raniga P; Ferris NJ; Woods RL; Storey E; Bailey MJ; Brodtmann A; Yates PA; Donnan GA; Trevaks RE; Wolfe R; Egan GF; McNeil JJ;
Int J Stroke; 2017 Jan; 12(1):108-113. PubMed ID: 27634976
[TBL] [Abstract][Full Text] [Related]
6. Prescription Medication Use in Older Adults Without Major Cardiovascular Disease Enrolled in the Aspirin in Reducing Events in the Elderly (ASPREE) Clinical Trial.
Lockery JE; Ernst ME; Broder JC; Orchard SG; Murray A; Nelson MR; Stocks NP; Wolfe R; Reid CM; Liew D; Woods RL;
Pharmacotherapy; 2020 Oct; 40(10):1042-1053. PubMed ID: 33078479
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial of low-dose aspirin for the prevention of fractures in healthy older people: protocol for the ASPREE-Fracture substudy.
Barker AL; McNeil JJ; Seeman E; Ward SA; Sanders KM; Khosla S; Cumming RG; Pasco JA; Bohensky MA; Ebeling PR; Woods RL; Lockery JE; Wolfe R; Talevski J;
Inj Prev; 2016 Aug; 22(4):297-301. PubMed ID: 26002770
[TBL] [Abstract][Full Text] [Related]
8. Slowing the progression of age-related hearing loss: Rationale and study design of the ASPIRIN in HEARING, retinal vessels imaging and neurocognition in older generations (ASPREE-HEARING) trial.
Lowthian JA; Britt CJ; Rance G; Lin FR; Woods RL; Wolfe R; Nelson MR; Dillon HA; Ward S; Reid CM; Lockery JE; Nguyen TT; McNeil JJ; Storey E;
Contemp Clin Trials; 2016 Jan; 46():60-66. PubMed ID: 26611434
[TBL] [Abstract][Full Text] [Related]
9. Daily Low-Dose Aspirin and Risk of Serious Falls and Fractures in Healthy Older People: A Substudy of the ASPREE Randomized Clinical Trial.
Barker AL; Morello R; Thao LTP; Seeman E; Ward SA; Sanders KM; Cumming RG; Pasco JA; Ebeling PR; Woods RL; Wolfe R; Khosla S; Hussain SM; Ronaldson K; Newman AB; Williamson JD; McNeil JJ
JAMA Intern Med; 2022 Dec; 182(12):1289-1297. PubMed ID: 36342703
[TBL] [Abstract][Full Text] [Related]
10. Cancer history and risk factors in healthy older people enrolling in the ASPREE clinical trial.
Orchard SG; Lockery JE; Gibbs P; Polekhina G; Wolfe R; Zalcberg J; Haydon A; McNeil JJ; Nelson MR; Reid CM; Kirpach B; Murray AM; Woods RL;
Contemp Clin Trials; 2020 Sep; 96():106095. PubMed ID: 32739494
[TBL] [Abstract][Full Text] [Related]
11. Daily low-dose aspirin and incident type 2 diabetes in community-dwelling healthy older adults: a post-hoc analysis of efficacy and safety in the ASPREE randomised placebo-controlled trial.
Zoungas S; Zhou Z; Owen AJ; Curtis AJ; Espinoza SE; Ernst ME; Woods RL; Orchard SG; McNeil JJ; Murray AM; Nelson MR; Reid CM; Ryan J; Wolfe R
Lancet Diabetes Endocrinol; 2024 Feb; 12(2):98-106. PubMed ID: 38142708
[TBL] [Abstract][Full Text] [Related]
12. A Thorough Literature Review of the Potential Benefits and Drawbacks of Long-Term Aspirin Use for the Primary Prevention of Cardiovascular Disease.
Shubietah ARM; Marin MP; Rajab IM; Oweidat MH; Zayed A; Hmeedan A
Cardiol Rev; 2024 May; ():. PubMed ID: 38785443
[TBL] [Abstract][Full Text] [Related]
13. The Study of Neurocognitive Outcomes, Radiological and Retinal Effects of Aspirin in Sleep Apnoea- rationale and methodology of the SNORE-ASA study.
Ward SA; Storey E; Woods RL; Hamilton GS; Kawasaki R; Janke AL; Naughton MT; O'Donoghue F; Wolfe R; Wong TY; Reid CM; Abhayaratna WP; Stocks N; Trevaks R; Fitzgerald S; Hodgson LAB; Robman L; Workman B; McNeil JJ;
Contemp Clin Trials; 2018 Jan; 64():101-111. PubMed ID: 29097299
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study.
Nelson MR; Reid CM; Ames DA; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Krum H; Storey E; Tonkin A; Wolfe R; Woods R; McNeil JJ
Med J Aust; 2008 Jul; 189(2):105-9. PubMed ID: 18637782
[TBL] [Abstract][Full Text] [Related]
15. Similar mortality risk in incident cognitive impairment and dementia: Evidence from the ASPirin in Reducing Events in the Elderly (ASPREE) trial.
Lin X; Banaszak-Holl J; Xie J; Ward SA; Brodaty H; Storey E; Shah RC; Murray A; Ryan J; Orchard SG; Fitzgerald SM; McNeil JJ
J Am Geriatr Soc; 2021 Dec; 69(12):3568-3575. PubMed ID: 34533211
[TBL] [Abstract][Full Text] [Related]
16. Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease.
Wolfe R; Wetmore JB; Woods RL; McNeil JJ; Gallagher H; Roderick P; Walker R; Nelson MR; Reid CM; Shah RC; Ernst ME; Lockery JE; Tonkin AM; Abhayaratna WP; Gibbs P; Wood EM; Mahady SE; Williamson JD; Donnan GA; Cloud GC; Murray AM; Polkinghorne KR
Kidney Int; 2021 Feb; 99(2):466-474. PubMed ID: 32920022
[TBL] [Abstract][Full Text] [Related]
17. The ASPREE Healthy Ageing Biobank: Methodology and participant characteristics.
Parker EJ; Orchard SG; Gilbert TJ; Phung JJ; Owen AJ; Lockett T; Nelson MR; Reid CM; Tonkin AM; Abhayaratna WP; Gibbs P; McNeil JJ; Woods RL
PLoS One; 2024; 19(2):e0294743. PubMed ID: 38421995
[TBL] [Abstract][Full Text] [Related]
18. Association of Plasma High-Density Lipoprotein Cholesterol Level With Risk of Fractures in Healthy Older Adults.
Hussain SM; Ebeling PR; Barker AL; Beilin LJ; Tonkin AM; McNeil JJ
JAMA Cardiol; 2023 Mar; 8(3):268-272. PubMed ID: 36652261
[TBL] [Abstract][Full Text] [Related]
19. Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults: A Prospective Cohort Study.
Zhou Z; Ryan J; Tonkin AM; Zoungas S; Lacaze P; Wolfe R; Orchard SG; Murray AM; McNeil JJ; Yu C; Watts GF; Hussain SM; Beilin LJ; Ernst ME; Stocks N; Woods RL; Zhu C; Reid CM; Shah RC; Chong TT; Sood A; Sheets KM; Nelson MR
Neurology; 2023 Nov; 101(22):e2288-e2299. PubMed ID: 37879942
[TBL] [Abstract][Full Text] [Related]
20. Baseline characteristics and age-related macular degeneration in participants of the "ASPirin in Reducing Events in the Elderly" (ASPREE)-AMD trial.
Robman LD; Phuong Thao LT; Guymer RH; Wolfe R; Woods RL; Hodgson LA; Phung J; Makeyeva GA; Le-Pham YA; Orchard SG; Suleiman J; Maguire E; Trevaks RE; Ward SA; Riaz M; Lacaze P; Storey E; Abhayaratna WP; Nelson MR; Ernst ME; Reid CM; McNeil JJ;
Contemp Clin Trials Commun; 2020 Dec; 20():100667. PubMed ID: 33210016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
